- Recruiting
NCT04458831: A Non-interventional, Multinational, Observational study With Isatuximab in RRMM
IONA-MM
NCT04458831: A Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) (IONA-MM)

NCT04458831: A Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) (IONA-MM)
To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months
Sponsor
Sanofi
ClinicalTrials.gov Identifier: NCT04458831
Official Title: A Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)
First Posted : July 7, 2020
Click here to see details on ClinicalTrials.gov
Drug: isatuximab SAR650984
Drug: Pomalidomide
Drug: Dexamethasone
Drug: Carfilzomib
Isatuximab : National Cancer Institute
Isatuximab : MedlinePlus Drug Information
Locations